Investor · 1 deal
Every published round Rohto Pharmaceutical took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Australis Scientific | Unnamed stage | Nov 2025 | $9.3m | Lead | Startup Daily, SmartCompany |
Companies Rohto Pharmaceutical has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Australis Scientific | Nov 2025 | 1 | 1 |
Fund closes reported for Rohto Pharmaceutical, as distinct from the investments it has made.
Companies Rohto Pharmaceutical has backed that another company then bought. An exit for the holding, not a deal Rohto Pharmaceutical did.
Stories naming Rohto Pharmaceutical. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Funding roundup covering four raises: Pay.com.au's $25 million round plus a $28 million secondary, Ruminant Biotech's Series A, Australis Scientific's Rohto-backed funding, and Paperly's $3 million round led by Tribe Global Ventures.